Literature DB >> 3048490

Specificity of monoclonal antibody Campath-1.

G Hale, H Waldmann, M Dyer.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3048490

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  Immunosuppressive preconditioning or induction regimens : evidence to date.

Authors:  Henkie P Tan; Marc C Smaldone; Ron Shapiro
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.

Authors:  Ngoc L Thai; Akhtar Khan; Kusum Tom; Deanna Blisard; Amit Basu; Henkie P Tan; Amadeo Marcos; John J Fung; Thomas E Starzl; Ron Shapiro
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

3.  Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.

Authors:  Ron Shapiro; Amit Basu; Henkie Tan; Edward Gray; Akhtar Kahn; Parmjeet Randhawa; Noriko Murase; Adriana Zeevi; Alin Girnita; Diana Metes; Roberta Ness; Debra C Bass; Anthony J Demetris; John J Fung; Amadeo Marcos; Thomas E Starzl
Journal:  J Am Coll Surg       Date:  2005-04       Impact factor: 6.113

4.  Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.

Authors:  Amadeo Marcos; Bijan Eghtesad; John J Fung; Paulo Fontes; Kusum Patel; Michael Devera; Wallis Marsh; Timothy Gayowski; Anthony J Demetris; Edward A Gray; Bridget Flynn; Adriana Zeevi; Noriko Murase; Thomas E Starzl
Journal:  Transplantation       Date:  2004-10-15       Impact factor: 4.939

5.  Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.

Authors:  Kenneth R McCurry; Aldo Iacono; Adrianna Zeevi; Samuel Yousem; Alin Girnita; Shahid Husain; Diana Zaldonis; Bruce Johnson; Brack G Hattler; Thomas E Starzl
Journal:  J Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 5.209
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.